Lipo6 Dynamix Blackberry Lemonade
Lipo6 Dynamix Blackberry Lemonade is a nootropic supplement designed to support cognitive function and energy. It features a 'Cognitive Enhancing Nootropic Blend' at 926.000NP (proprietary blend, dosage not fully disclosed for individual components) and a 'Lipo Lytic Blend' at 327.000mg (also proprietary). Key disclosed ingredients include Caffeine at 175.000mg, which can support alertness, and Methylliberine at 125.000mg. The product received an N+ Score of 53, resulting in an 'F' grade, placing it in the below-average tier. Its 100% label transparency is a positive, but the use of proprietary blends for key nootropic components limits specific ingredient dosage evaluation, contributing to low formula completeness and ingredient adequacy scores. This product may appeal to individuals seeking an energy boost and general cognitive support, but the proprietary blends make it difficult to assess the efficacy of individual nootropic compounds.
About This Product
Lipo6 Dynamix Blackberry Lemonade by Nutrex Research is a nootropics supplement containing 4 active ingredients. It has earned an N+ Score of 53/100 (Grade F).
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (4 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Caffeine | 175.000 mg | N/A |
| Methylliberine | 125.000 mg | N/A |
| Cognitive Enhancing Nootropic Blend | 926.000 NP | N/A |
| Lipo Lytic Blend | 327.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.